Navigation Links
Feinstein Institute Researcher Joins International Partnership in Neuroscience Research

Manhasset, NY (PRWEB) December 18, 2013

The Feinstein Institute for Medical Research Monday hosted the signing of a Memorandum of Understanding (MOU) dedicated to creating a partnership in neuroscience research, and in particular, research on Alzheimer’s disease. US Reps. Steve Israel (D-NY), and Chakah Fattah (D-PA), along with Feinstein Institute Investigator Peter Davies, PhD, and representatives from other research institutions signed the MOU.

“I am confident that groundbreaking research will come from this partnership that will bring us closer to understanding the brain and finding a treatment, cure or prevention method for Alzheimer’s disease,” said Rep. Israel. “Both Representative Fattah and I have been staunch advocates in Congress for more research for neuroscience and Alzheimer’s disease, and today’s announcement is an important step forward.”

Other institutions joining the partnership were: Cold Spring Harbor Lab, University of Pennsylvania, Temple University and Israel Brain Technologies in Ramat Hasharon, Israel.

“It is absolutely essential that scientists involved in neuroscience and Alzheimer’s disease collaborate. We will not cure Alzheimer’s disease by ourselves,” said Peter Davies, PhD, director of the Litwin-Zucker Research Center for the Study of Alzheimer’s Disease at The Feinstein Institute for Medical Research. “This collaboration represents a concrete step in bringing together five groups that have real interest and commitment to finding effective treatments.”

Barring new medical breakthroughs to prevent, slow or stop the disease, and as the US population gets older and life expectancy increases, the number of people age 65 and older with Alzheimer’s will nearly triple by 2050. Furthermore, total payments for health care, long-term care and hospice for people with Alzheimer's and other dementias are projected to increase to $1.2 trillion in 2050. Even though Alzheimer’s disease is devastating, pervasive and costly, federal funding of research in this area is very low – $400 million per year is dedicated to Alzheimer’s research versus $6 billion per year for cancer research.

The announcement comes one month after Dr. Davies and Rep. Israel announced the formation of the Long Island Alzheimer’s Disease Consortium and that Rep Israel and State Assemblyman Charles Lavine are collaborating with the consortium to create a ten-year bond that would allocate per year $7 of each NY tax payer’s payments to Alzheimer’s disease research. This would add up to $1 billion dedicated to Alzheimer’s disease research.

About Peter Davies, PhD

Peter Davies, PhD, is the director of the Litwin-Zucker Research Center for the Study of Alzheimer’s Disease at The Feinstein Institute for Medical Research. The Feinstein’s Litwin Zucker Center is the only dedicated Alzheimer’s disease research facility on Long Island. Dr. Davies and his colleagues have conducted dozens of research studies and enrolled thousands of study participants in hopes of identifying new ways to detect and treat Alzheimer’s disease. For more information about the Litwin-Zucker Research Center, call (516) 562-3492.

About The Feinstein Institute for Medical Research

Headquartered in Manhasset, NY, The Feinstein Institute for Medical Research is home to international scientific leaders in many areas including Parkinson's disease, Alzheimer’s disease, psychiatric disorders, rheumatoid arthritis, lupus, sepsis, human genetics, pulmonary hypertension, leukemia, neuroimmunology, and medicinal chemistry. The Feinstein Institute, part of the North Shore-LIJ Health System, ranks in the top 6th percentile of all National Institutes of Health grants awarded to research centers. For more information, visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Feinstein Institute to receive grant to improve schizophrenia treatment
2. Feinstein Institute to Receive Grant from Centers for Medicare & Medicaid Services to Improve Schizophrenia Treatment
3. Feinstein Institute researchers discover that bean used in Chinese food could protect against sepsis
4. Feinstein announces submission of new drug application for diagnosing parkinsonian syndromes
5. Feinstein Institute researchers discover plant derivative
6. A Feinstein Institute for Medical Research Study Shows Early Cognitive Problems among Those Who Eventually Get Alzheimer's
7. Feinstein Institute Scientist Wins Crafoord Award from Royal Swedish Academy of Sciences for Arthritis Research
8. Feinstein Institute Researcher provides insight into osteoarthritis
9. North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week
10. North Shore-LIJ's Feinstein Institute Hosts Academic Commencement and Convocation
11. Feinstein Institute, Hofstra North Shore-LIJ School of Medicine at 36th Annual Conference on Shock
Post Your Comments:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Dr. Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile ... orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016  MedSource announced ... as its e-clinical software solution of choice.  This ... best possible value to their clients by offering ... The preferred relationship establishes nowEDC as the EDC ... for MedSource,s full-service clients.  "nowEDC has long been ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 Roche ... received 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) ... severe sepsis or septic shock. With this clearance, Roche ... provide a fully integrated solution for sepsis risk assessment ... associated with bacterial infection and PCT levels in blood ...
(Date:6/23/2016)... Calif. , June 23, 2016 ... CST on Thursday, July 7, 2016 , , , , ... ) , , , , EXPERT PANELISTS:  , , ... Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar ... The global pharmaceutical industry is witnessing an exceptional ...
Breaking Medicine Technology: